BG00012 and Delay of Disability Progression in Secondary Progressive Multiple Sclerosis

PHASE3TerminatedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Multiple Sclerosis, Secondary Progressive
Interventions
DRUG

dimethyl fumarate

capsule

OTHER

Placebo

matched placebo capsule

Trial Locations (18)

1200

Research Site, Brussels

19001

Research Site, Willow Grove

28207

Research Site, Charlotte

32960

Research Site, Vero Beach

33634

Research Site, Tampa

78681

Research Site, Round Rock

90806

Research Site, Long Beach

94143

Research Site, San Francisco

97404

Research Site, Banská Bystrica

656 91

Research Site, Brno

500 05

Research Site, Hradec Králové

6162 BG

Research Site, Sittard-Geleen

80-803

Research Site, Gdansk

Unknown

Research Site, Katowice

31-505

Research Site, Krakow

93-121

Research Site, Lodz

62-064

Research Site, Plewiska

61-853

Research Site, Poznan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY